Close Menu

There are myriad targets that have been deemed undruggable and they "have rankled even the best-funded laboratories over the years," The Scientist says. However, some biotechs are game for taking those impossible targets on — and they appear to be seeing some success. The Scientist notes that one of those companies, Anchor Therapeutics, is working on targeting membrane receptors for Novartis and Ortho-McNeil-Janssen Pharmaceuticals.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.